The contractor shall provide scientific writers-editors to support division of vaccines and related biological products advisory (dvrpa) staff who have responsibility for review of regulatory…
Ended Awarded Last action
- Contract number
- 75F40123F19005
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,862,130
Award facts
- Contract value 100% obligated
- $1,862,129.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$257,665 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $731,234 | |
| Other Administrative Action | $0 | |
| Original award | $1,388,561 |
About this award
The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on June 30, 2023, with a ceiling value of $1.862 million under the 8(a) Sole Source set-aside. The order calls for scientific writers-editors to support the Division of Vaccines and Related Biological Products Advisory staff in review of regulatory submissions and preparation of review memoranda. Ultimate completion date was August 5, 2025.
Place of performance is Silver Spring, Maryland. The order is priced on a labor-hours basis. Service Contract Inventory reporting through FY2025 shows the order invoiced $181 thousand in FY2024 (0.8 FTEs, 1,591 contractor hours) and $549 thousand in FY2025 (2.3 FTEs, 4,841 contractor hours), with a derived government-paid hourly rate of approximately $113.51 to $113.91 per hour. In FY2025, all contractor hours were subcontracted, with two named subcontractors performing the work.
Description
The contractor shall provide scientific writers-editors to support division of vaccines and related biological products advisory (dvrpa) staff who have responsibility for review of regulatory submissions and preparation of review memoranda, advisory
Quick answers
Who was awarded contract 75F40123F19005?
75F40123F19005 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on June 30, 2023.
How much is contract 75F40123F19005 worth?
The government has obligated $1,862,130 on 75F40123F19005.
Is contract 75F40123F19005 an order under another contract?
Yes. 75F40123F19005 is a delivery order under 75F40122D00018, an indefinite delivery contract.
Was contract 75F40123F19005 competed?
The extent of competition for 75F40123F19005 was not available for competition. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award